The effects of the endocannabinoids anandamide and 2-arachidonoylglycerol on human osteoblast proliferation and differentiation

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Smith, Marie ^a   Wilson, Richard ^a   O'Brien, Sally ^a   Tufarelli, Cristina ^a   Anderson, Susan I ^a   O'Sullivan, Saoirse Elizabeth ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ALKALINE PHOSPHATASE; ANANDAMIDE; CALCIUM; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; COLLAGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCALCIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; VANILLOID RECEPTOR 1; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CNR2 PROTEIN, HUMAN; CREB1 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; ENDOCANNABINOID; GLYCERYL 2-ARACHIDONATE; MITOGEN ACTIVATED PROTEIN KINASE; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ARTICLE; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; COLLAGEN METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; ENZYME INHIBITION; ENZYME SYNTHESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

ANTIGENS, DIFFERENTIATION; ARACHIDONIC ACIDS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOCANNABINOIDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCERIDES; HUMANS; OSTEOBLASTS; PHOSPHORYLATION; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TRPV CATION CHANNELS;

EID: 84946944843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136546     Document Type: Article

References (49)

1. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3 Suppl 3: S131-139. doi: 10.2215/CJN.04151206 PMID: 18988698
2. Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66: 101-121. PMID: 12052030
3. Di Marzo V, Petrosino S (2007) Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 18: 129-140. PMID: 17353660
4. Di Marzo V (2011) Endocannabinoids: an appetite for fat. Proc Natl Acad Sci U S A 108: 12567-12568. doi: 10.1073/pnas.1109567108 PMID: 21778404
5. Pertwee RG (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17: 1360-1381. PMID: 20166927
6. Rossi F, Siniscalco D, Luongo L, De Petrocellis L, Bellini G, et al. (2009) The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 44: 476-484. doi: 10.1016/j.bone.2008.10.056 PMID: 19059369
7. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, et al. (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106: 16511-16516. doi: 10.1073/pnas.0902743106 PMID: 19805329
8. Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, et al. (2005) Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11: 774-779. PMID: 15908955
9. Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, et al. (2009) Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab 10: 139-147. doi: 10.1016/j.cmet.2009.07.006 PMID: 19656492
10. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, et al. (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103: 696-701. PMID: 16407142
11. Idris AI, Landao-Bassonga E, Ralston SH (2010) The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo. Bone 46: 1089-1099. doi: 10.1016/j.bone.2010.01.368 PMID: 20096813
12. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, et al. (2005) Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25: 3126-3131. PMID: 15788769
13. Tam J, Ofek O, Fride E, Ledent C, Gabet Y, et al. (2006) Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 70: 786-792. PMID: 16772520
14. Whyte LS, Ford L, Ridge SA, Cameron GA, Rogers MJ, et al. (2012) Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. Br J Pharmacol 165: 2584-2597. doi: 10.1111/ j.1476-5381.2011.01519.x PMID: 21649637
15. Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, et al. (2008) The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 22: 285-294. PMID: 17704191
16. Rossi F, Bellini G, Luongo L, Torella M, Mancusi S, et al. (2011) The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. Bone 48: 997-1007. doi: 10.1016/j.bone. 2011.01.001 PMID: 21237298
17. Hutchins HL, Li Y, Hannon K, Watkins BA (2011) Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. J Nutr Biochem 22: 195-200. doi: 10.1016/j.jnutbio.2010.06.001 PMID: 20951563
18. Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A (2008) Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 20 Suppl 1: 69-74. doi: 10.1111/j.1365-2826.2008.01675.x PMID: 18426503
19. Idris AI, Sophocleous A, Landao-Bassonga E, van't Hof RJ, Ralston SH (2008) Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology 149: 5619-5626. doi: 10.1210/en.2008-0150 PMID: 18635663
20. Sophocleous A, Landao-Bassonga E, Van't Hof RJ, Idris AI, Ralston SH (2011) The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. Endocrinology 152: 2141-2149. doi: 10.1210/en.2010-0930 PMID: 21447627
21. Scutt A, Williamson EM (2007) Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcif Tissue Int 80: 50-59. PMID: 17205329
22. Henstock JR, Ruktanonchai UR, Canham LT, Anderson SI (2014) Porous silicon confers bioactivity to polycaprolactone composites in vitro. J Mater Sci Mater Med 25: 1087-1097. doi: 10.1007/s10856- 014-5140-5 PMID: 24398914
23. Anderson SI, Downes S, Perry CC, Caballero AM (1998) Evaluation of the osteoblast response to a silica gel in vitro. J Mater Sci Mater Med 9: 731-735. PMID: 15348931
24. Di Silvio L (1995) A novel application of two biomaterials for the delivery of growth hormone and its effect on osteoblasts: UCL.
25. Huang J, Di Silvio L, Wang M, Tanner KE, BonfieldW(1997) In vitro mechanical and biological assessment of hydroxyapatite-reinforced polyethylene composite. J Mater Sci Mater Med 8: 775-779. PMID: 15348789
26. Franceschi RT, Iyer BS, Cui Y (1994) Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 9: 843-854. PMID: 8079660
27. Yamanouchi K, Gotoh Y, Nagayama M (1997) Dexamethasone enhances differentiation of human osteoblastic cells in vitro. Journal of Bone and Mineral Metabolism 15: 23-29.
28. Yang L, Tao T, Wang X, Du N, Chen W, et al. (2003) Effects of dexamethasone on proliferation, differentiation and apoptosis of adult human osteoblasts in vitro. Chin Med J (Engl) 116: 1357-1360.
29. Fratzl-Zelman N, Fratzl P, Horandner H, Grabner B, Varga F, et al. (1998) Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. Bone 23: 511-520. PMID: 9855459
30. Henstock JR (2009) Porous Silicon-Polycaprolactone Composites for Orthopaedic Tissue Engineering. Available: http://eprints.nottingham.ac.uk/11022/: University of Nottingham.
31. Hind WH, Tufarelli C, Neophytou M, Anderson SI, England TJ, et al. (2015) Endocannabinoids modulate human blood-brain barrier permeability in vitro. Br J Pharmacol 172: 3015-3027. doi: 10.1111/ bph.13106 PMID: 25651941
32. Aubin JE (2001) Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2: 81-94. PMID: 11704982
33. Hind WH, Tufarelli C, Neophytou M, Anderson SI, England TJ, et al. (2015) Endocannabinoids modulate human blood-brain barrier permeability in vitro. Br J Pharmacol.
34. Zhou H, Choong P, McCarthy R, Chou ST, Martin TJ, et al. (1994) In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9: 1489-1499. PMID: 7817834
35. Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, et al. (2005) Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 14: 3389-3396. PMID: 16204352
36. Bab I, Zimmer A, Melamed E (2009) Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Ann Med 41: 560-567. doi: 10.1080/07853890903121025 PMID: 19634029
37. Gui H, Tong Q, Qu W, Mao CM, Dai SM (2015) The endocannabinoid system and its therapeutic implications in rheumatoid arthritis. Int Immunopharmacol 26: 86-91. doi: 10.1016/j.intimp.2015.03.006 PMID: 25791728
38. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, et al. (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275: 9645-9652. PMID: 10734116
39. Ge C, Xiao G, Jiang D, Franceschi RT (2007) Critical role of the extracellular signal-regulated kinase- MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176: 709-718. PMID: 17325210
40. Zhang R, Edwards JR, Ko SY, Dong S, Liu H, et al. (2011) Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts. PLoS One 6: e20780. doi: 10.1371/journal. pone.0020780 PMID: 21695256
41. Huang YF, Lin JJ, Lin CH, Su Y, Hung SC (2012) c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104. J Bone Miner Res 27: 1093-1105. doi: 10.1002/jbmr.1548 PMID: 22247071
42. Doan TKP, Park KS, Kim HK, Park DS, Kim JH, et al. (2012) Inhibition of JNK and ERK pathways by SP600125- and U0126-enhanced osteogenic differentiation of bone marrow stromal cells. Tissue Engineering and Regenerative Medicine 9: 283-294.
43. Kim BS, Kang HJ, Park JY, Lee J (2015) Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells. Exp Mol Med 47: e128. doi: 10.1038/emm.2014.95 PMID: 25572360
44. Zhang X, Zhou C, Zha X, Xu Z, Li L, et al. (2015) Apigenin promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways. Mol Cell Biochem.
45. Ducy P (2011) The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54: 1291-1297. doi: 10.1007/s00125-011-2155-z PMID: 21503740
46. Ducy P, Desbois C, Boyce B, Pinero G, Story B, et al. (1996) Increased bone formation in osteocalcindeficient mice. Nature 382: 448-452. PMID: 8684484
47. Zhao M, Edwards J, Ko S, Parlato R, Harris S, et al. (2009) CREB induces BMP2 transcription in osteoblasts and CREB knockout reduces bone mass in mice. Bone 44: S27.
48. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, et al. (2003) Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365. PMID: 12782654
49. Mukherjee A, Rotwein P (2009) Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci 122: 716-726. doi: 10.1242/jcs.042770 PMID: 19208758